Plain-English translation of NCT04054310 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is evaluating whether special MRI scans can more accurately detect and measure fatty liver disease. Researchers want to see if MRI imaging — which uses magnetic fields to create detailed pictures of the liver — can help doctors better understand who has advanced liver disease and who doesn't. This could eventually mean fewer people need to undergo invasive biopsies.
Current methods to diagnose fatty liver disease sometimes lead doctors to perform unnecessary biopsies on patients who don't actually have the disease. This study aims to find a non-invasive way to identify which patients truly need a biopsy, reducing unnecessary procedures and helping doctors diagnose liver disease more accurately.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will complete an MRI scan of your liver (which takes 15–30 minutes in a scanner) and then undergo a standard liver biopsy as planned with your doctor. The study is designed to compare the MRI results with the biopsy findings to see how well the MRI can detect and measure liver disease. You will have no additional visits beyond your already-scheduled biopsy appointment.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States